Fed. Circ. Upholds Validity Of Sanofi's Plavix Patent
The U.S. Court of Appeals for the Federal Circuit on Friday affirmed a June 2007 decision by a New York district court that rejected Apotex’s claims that the patent related to clopidogrel bisulphate was invalid due to anticipation and obviousness.
By affirming the patent’s validity, the Federal Circuit also effectively upheld the U.S....
To view the full article, register now.